China Universal Asset Management Company’s Cabaletta Bio CABA Stock Holding History

China Universal Asset Management Company’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$46K	Buy	17,083 +1,397	+9%	+$3.88K	﹤0.01%	461
2025 Q4	$34.4K	Buy	+15,686	New	+$38.9K	﹤0.01%	470
2024 Q4	–	Sell	-9,395	Closed	-$44.3K	–	502
2024 Q3	$44.3K	Buy	9,395 +3,724	+66%	+$21.5K	﹤0.01%	391
2024 Q2	$42.4K	Sell	5,671 -2,535	-31%	-$31.1K	0.01%	367
2024 Q1	$140K	Buy	8,206 +3,244	+65%	+$69.6K	0.02%	335
2023 Q4	$113K	Buy	+4,962	New	+$83.4K	0.02%	270
2022 Q4	–	Sell	-272	Closed	–	–	405
2022 Q3	$0	Buy	+272	New	+$328	﹤0.01%	441

Other funds holding CABA

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

China Universal Asset Management Company's CABA Position: Q1 2026 in Review

China Universal Asset Management Company increased its Cabaletta Bio (CABA) stake by 8.9% in Q1 2026, buying an estimated $3.88K and bringing the position to 17,083 shares worth $46K. The position accounts for ﹤0.01% of the portfolio, ranked #461.

China Universal Asset Management Company first reported a position in CABA in Q3 2022 and has held it in 7 quarters since. The position peaked at $140K in Q1 2024. 108 funds tracked by Wall St. Rank hold CABA as of Q1 2026.

China Universal Asset Management Company held 17,083 shares of Cabaletta Bio worth $46K as of Q1 2026.
China Universal Asset Management Company bought 1,397 Cabaletta Bio shares in Q1 2026, an estimated $3.88K.
Cabaletta Bio made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q1 2026, its #461 holding.
China Universal Asset Management Company first reported a position in Cabaletta Bio in Q3 2022 and has held it in 7 quarters since.
China Universal Asset Management Company's Cabaletta Bio position peaked at $140K in Q1 2024.
108 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2026.

Based on China Universal Asset Management Company's 13F filing for Q1 2026, filed 28 Apr 2026.